SANUWAVE forecasts Q2 2026 revenue USD 9.6 million-USD 9.8 million, above revised guidance range

Sanuwave Health, Inc.

Sanuwave Health, Inc.

SNWV

0.00
  • SANUWAVE forecast Q2 2026 revenue of $9.6-$9.8 million, topping the revised guidance range of $8.5-$9.5 million.
  • Preliminary Q2 revenue implies a 3%-5% decline from $10.1 million in Q2 2025.
  • Management cited headwinds in capital sales from customer stress, partly offset by record consumable applicator unit sales and revenue.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SANUWAVE Health Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607131630PRIMZONEFULLFEED9761175) on July 13, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.